Skip to main content
OpenTrials

Clinical trial condition

Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)

Explore clinical trials studying Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN). Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN) trial results

Recruiting

Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study

NCT07746895

Conditions
C3 Glomerulopathy (C3G), Disease Attributes, Female Urogenital Diseases, +11 more
Locations
  • Nepean Hospital Kingswood, Australia
  • Princess Alexandra Hospital Woolloongabba, Australia
  • Medizinische Universität Graz Graz, Austria
  • Uniklinik Innsbruck Innsbruck, Austria
View all 101 locations
View Trial Details
Active, not recruiting

An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05809531

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Academic Medical Research Institute (01034) Los Angeles, California, United States
  • Children's Hospital Colorado (01037) Aurora, Colorado, United States
  • University of Florida, Department of Pediatric Nephrology (01010) Gainsville, Florida, United States
  • Emory Investigational Drug Service (01021) Atlanta, Georgia, United States
View all 47 locations
View Trial Details
Completed

Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN

NCT04572854

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Keck School of Medicine, University of Southern California Los Angeles, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Mayo Clinic Rochester, Minnesota, United States
View all 25 locations
View Trial Details
Completed

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

NCT05067127

Conditions
C3 Glomerulonephritis, C3 Glomerulopathy, C3G, +19 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Academic Medical Research Institute Los Angeles, California, United States
  • Keck School of Medicine, University of Southern California Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center (01035) Los Angeles, California, United States
View all 125 locations
View Trial Details

Related conditions